《系统综述与Meta分析报告的规范(PRISMA)2020声明:针对实时系统综述的扩展(PRISMA-LSR)》:清单及解释
Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation.
作者信息
Akl Elie A, Khabsa Joanne, Iannizzi Claire, Piechotta Vanessa, Kahale Lara A, Barker James M, McKenzie Joanne E, Page Matthew J, Skoetz Nicole
机构信息
Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
出版信息
BMJ. 2024 Nov 19;387:e079183. doi: 10.1136/bmj-2024-079183.
Publications of living systematic reviews (LSRs) are increasing rapidly. Guidance facilitating transparent, complete, and accurate reporting of LSRs is needed. This paper reports the development of an extension of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 statement for LSRs (PRISMA-LSR). The PRISMA-LSR extension includes the PRISMA-LSR checklist, the PRISMA-LSR flow diagram, reporting recommendations for the LSR status, and an explanation and elaboration document. This extension has been developed as an “add-on” to the PRISMA 2020 statement, meaning it should be used in addition to the PRISMA 2020 statement. The PRISMA-LSR extension is expected to benefit authors, editors, peer reviewers, and users of LSRs through transparent, complete, and accurate reporting of LSRs.
实时系统评价(LSR)的发表数量正在迅速增加。因此需要有助于透明、完整和准确报告LSR的指南。本文报告了针对LSR的《系统评价与Meta分析优先报告条目》(PRISMA)2020声明扩展版(PRISMA-LSR)的制定情况。PRISMA-LSR扩展版包括PRISMA-LSR清单、PRISMA-LSR流程图、LSR状态的报告建议以及一份解释与阐述文件。此扩展版是作为PRISMA 2020声明的“附加内容”开发的,这意味着它应与PRISMA 2020声明一起使用。预计PRISMA-LSR扩展版将通过对LSR进行透明、完整和准确的报告,使LSR的作者、编辑、同行评审人员和使用者受益。
相似文献
Int J Equity Health. 2015-10-8
J Med Libr Assoc. 2021-4-1
Biol Rev Camb Philos Soc. 2021-10
Zhonghua Liu Xing Bing Xue Za Zhi. 2019-7-10
引用本文的文献
Cochrane Evid Synth Methods. 2025-3-28
本文引用的文献
Cochrane Database Syst Rev. 2023-11-30
Z Evid Fortbild Qual Gesundhwes. 2023-9
BMJ Evid Based Med. 2023-10
Cochrane Database Syst Rev. 2023-2-16
J Clin Epidemiol. 2023-4
J Clin Epidemiol. 2023-4